THOMPSON SIEGEL & WALMSLEY LLC - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 82 filers reported holding ENZO BIOCHEM INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
THOMPSON SIEGEL & WALMSLEY LLC ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q1 2016$62,000
+100.0%
13,600
+100.0%
0.00%0.0%
Q4 2015$31,000
+40.9%
6,8000.0%0.00%
Q3 2015$22,000
+4.8%
6,8000.0%0.00%
Q2 2015$21,000
+5.0%
6,8000.0%0.00%
Q1 2015$20,000
-33.3%
6,8000.0%0.00%
-100.0%
Q4 2014$30,000
-14.3%
6,8000.0%0.00%0.0%
Q3 2014$35,000
-2.8%
6,8000.0%0.00%0.0%
Q2 2014$36,000
+28.6%
6,8000.0%0.00%0.0%
Q1 2014$28,0006,8000.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q3 2015
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,436,771$7,822,00010.43%
VIEX Capital Advisors, LLC 1,736,087$5,573,0008.96%
HARBERT FUND ADVISORS, INC. 5,175,913$16,615,0004.19%
AMH Equity Ltd 596,742$1,916,0002.66%
Potomac Capital Management, Inc. 208,000$668,0000.59%
Agate Pass Investment Management, LLC 24,292$78,0000.05%
RBF Capital, LLC 250,359$804,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$82,0000.05%
Corsair Capital Management 58,657$188,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 319,500$1,026,0000.02%
View complete list of ENZO BIOCHEM INC shareholders